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Accumulation of unfolded protein within the endo-
plasmic reticulum (ER) attenuates mRNA translation
through PERK-mediated phosphorylation of eukary-
otic initiation factor 2 on Ser51 of the a subunit
(eIF2a). To elucidate the role of eIF2a phosphoryla-
tion, we engineered mice for conditional expression
of homozygous Ser51Ala mutant eIF2a. The absence
of eIF2a phosphorylation in b cells caused a severe
diabetic phenotype due to heightened and unregu-
lated proinsulin translation; defective intracellular
trafficking of ER cargo proteins; increased oxidative
damage; reduced expression of stress response
and b-cell-specific genes; and apoptosis. However,
glucose intolerance and b cell death in these mice
were attenuated by a diet containing antioxidant. We
conclude that phosphorylation of eIF2a coordinately
attenuates mRNA translation, prevents oxidative
stress, and optimizes ER protein folding to support
insulin production. The finding that increased proin-
sulin synthesis causes oxidative damage in b cells
may reflect events in the b cell failure associated with
insulin resistance in type 2 diabetes.
INTRODUCTION
The rough endoplasmic reticulum (ER) is a network of intercon-
nected tubules, vesicles, and sacs that serves many specialized
functions in the cell, including calciumstorage and gated release,
biosynthesis and folding of membrane and secretory proteins,
and production of lipids and sterols. Cells have a unique adaptive
capability to adjust and coordinate the ER protein-folding
capacity with the protein-folding load. One profound example of
physiological fluctuations in the protein-folding load is the unique
translational response of pancreatic b cells to variations in blood
glucose. Proinsulin synthesis imposes a heavy biosynthetic
burden upon the b cell, as 1 3 106 proinsulin molecules are
synthesized per minute upon glucose stimulation (Schuit et al.,
1988). Conditions that interfere with productive protein foldingin the ER lumen result in the accumulation of unfolded or mis-
folded (herein referred to as misfolded) proteins, a condition
known as ER stress. Accumulation of misfolded proteins within
the lumen of the ER in b cells occurs as a consequence of
increased proinsulin translation, expression of inherently mis-
folded proinsulin, defects in adaptive response-signaling path-
ways, and physiological stimuli, including glucose, cytokines,
lipids, and nitric oxide (Scheuner and Kaufman, 2008).
The unfolded protein response (UPR) is an adaptive signaling
program that evolved to resolve the accumulation of misfolded
proteins in the ER (Ron and Walter, 2007; Rutkowski and Kauf-
man, 2007). The UPR increases ER protein-folding capacity,
decreases protein synthesis to reduce the folding demand, and
enhances clearance of misfolded proteins. When these mecha-
nisms fail to reestablish ER homeostasis, numerous death-
signaling pathways are activated (Kim et al., 2008). Recent
studies suggest that there is a close interrelationship between
misfolded protein-mediated cell death and oxidative stress
(Malhotra and Kaufman, 2007). During disulfide bond formation
in the ER, electrons are transferred from cysteine residues
through protein disulfide isomerase (PDI) and ER oxidoreduc-
tase 1 (ERO1) to reduce molecular oxygen and form hydrogen
peroxide (Tu and Weissman, 2004). In addition, glutathione is
consumed in the process of reducing mispaired disulfide bonds
(Cuozzo and Kaiser, 1999) that may deplete the cellular gluta-
thione pool that is required to neutralize reactive oxygen species
(ROS) and prevent oxidation of cytosolic proteins. Therefore,
cells with a high biosynthetic load, defective UPR, or inadequate
ER-associated protein degradation (ERAD) are vulnerable to
oxidative stress (Harding et al., 2003; Malhotra et al., 2008;
Merksamer et al., 2008; Song et al., 2008). ER to mitochondria
calcium crosstalk may also compromise mitochondrial function
and induce oxidative stress in response to protein misfolding
(Sharaf El Dein et al., 2009). The studies suggest that the UPR
has evolved as a protective mechanism to prevent oxidative
stress associated with protein folding in the ER.
In metazoan cells, the UPR is signaled through three ER trans-
membrane sensors of unfolded protein: inositol-requiring 1a
(IRE1a), activating transcription factor 6a (ATF6a), and PKR-
like ER kinase (PERK) (Ron and Walter, 2007; Rutkowski and
Kaufman, 2007). IRE1a has ER stress-regulated kinase/endori-
bonuclease activities that initiate unconventional splicing of theCell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc. 13
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Translational Control Maintains Insulin ProductionmRNA encoding the X-box-binding protein 1 (XBP1) transcrip-
tion factor. ATF6a is a basic region/leucine zipper transcription
factor that is released from the membrane by regulated proteo-
lytic cleavage for trafficking to the nucleus. XBP1 and ATF6a act
in concert to induce transcription of genes to enhance protein
folding and degradation. However, to date, there is no direct
evidence that either IRE1a/XBP1 or ATF6a are important for
the function and/or viability of pancreatic b cells in vivo (Lee
et al., 2005; Wu et al., 2007; Yamamoto et al., 2007).
The third ER stress transducer, PERK, is a protein kinase that
phosphorylates eIF2a at Ser51, thereby reducing the level of
functional eIF2B to inhibit general mRNA translation (Hershey,
2000). The PERK/eIF2a pathway is not only responsible for
mRNA translation attenuation, but also plays a key role in tran-
scriptional control (Harding et al., 2000; Scheuner et al., 2001).
Phosphorylation of eIF2a is required for the selective translation
of some mRNAs, such as activating transcription factor 4 (Atf4)
mRNA (Harding et al., 2000). It is proposed that ATF4 promotes
cell survival by inducing expression of genes for amino acid
biosynthesis and transport, antioxidative stress responses, and
protein folding and secretion (Harding et al., 2003).
Four mammalian protein kinases, PERK, GCN2, PKR, and
HRI, phosphorylate eIF2a at Ser51 in response to different stress
conditions (Sonenberg and Hinnebusch, 2009). However, the
biological significance of PERK/eIF2a signaling is underscored
by the observation that mutations in Perk reduce b cell mass and
cause neonatal insulin-dependent diabetes in humans (Delepine
et al., 2000). Furthermore, null mutations in Perk and mutation at
the Ser51 phosphorylation site in eIF2a cause b cell deficiency
and diabetes in murine models (Harding et al., 2001; Scheuner
et al., 2001, 2005; Zhang et al., 2002). However, the mechanism
whereby PERK-mediated translational control through eIF2a
phosphorylation prevents b cell failure is unknown. To elucidate
the role of PERK/eIF2a signaling in b cells, we have engineered
mice with conditional homozygous eIF2a Ser51/Ala (herein, A/A)
mutation. In the absence of eIF2a phosphorylation, mRNA trans-
lation was not repressed by low glucose or ER stress. The condi-
tional loss of eIF2a phosphorylation and unrestricted translation
in differentiated b cells was sufficient to disrupt ER function and
cause oxidative damage. The consequences were defectiveinsulin trafficking from the ER to the Golgi complex and reduced
expression of b-cell-specific transcription factors. These events
lead to b cell failure and apoptosis that result in severe glucose
intolerance and hyperglycemia.
RESULTS
Ubiquitous Expression of a loxP-Flanked Wild-Type
eIF2a Transgene Rescues Lethality of Homozygous
eIF2a A/A Mice
b-cell-specific wild-type (WT) eIF2a expression restored b cell
mass and ultrastructure inA/A embryos, affirming that b cell defi-
ciency in the homozygousmutantmicewas due to an absence of
eIF2a phosphorylation in b cells and not another cell type that
influences b cell function (Figure S1 available online). However,
it did not prevent the postnatal lethality of A/A mutation (Table
S1), suggesting that neonatal viability requires eIF2a phosphor-
ylation in cell types additional to the b cell. To determine whether
ubiquitous expression of WT eIF2a could prevent the postnatal
lethality of homozygous A/A mice and study why b cells fail in
the absence of eIF2a phosphorylation, we derived mice that
express WT eIF2a from a loxP-flanked (floxed) WT eIF2a trans-
gene (fTg) (Experimental Procedures and Supplemental Experi-
mental Procedures). The transgene was designed to coordi-
nately induce green fluorescence protein (EGFP) expression
upon Cre recombinase-mediated deletion of the eIF2a-coding
region. Transgenic mice ubiquitously expressing fTg mRNA
from a single-copy transgene (Figures S2A–S2D) were bred with
heterozygous S/A mice (Supplemental Experimental Proce-
dures). Genotype and phenotype analyses of 1- to 2-month-
old offspring demonstrated that homozygous A/Amice carrying
the fTg (A/A;fTg/0) were viable (Table S2), had normal bodymass
(Table S3), and were morphologically indistinguishable from
control heterozygous S/A littermates (data not shown). Western
blot analysis of islets revealed that total eIF2a protein expression
was increased 2-fold in A/A;fTg/0 islets compared to S/A islets
(Figures S2E and S2F). Glucose tolerance tests (GTT), insulin
production, and ultrastructural analyses indicated that the b cells
from homozygous A/A mice harboring the fTg were functionalFigure 1. Ubiquitous Expression of a FloxedWT eIF2a Transgene in Homozygous eIF2a A/AMice Prevents Lethality, Preserves bCell Mass,
and Is Required for Glucose-Regulated Protein Synthesis
(A) Diagram depicts the four genotypes of mice used in these experiments. Heterozygous eIF2a S/A mice harbor Ser51Ala (*) mutation in exon 2 of one eIF2a
allele. fTg/0 represents the floxedWT eIF2a transgene driven by theCMV enhancer and chicken b-actin promoter (Enh-Pro). LoxP sequences (black arrowheads)
allow excision of eIF2a-coding sequence and coordinate expression of EGFP. CreER/0 represents the CreER recombinase transgene driven by the rat insulin II
promoter (RIP). The deletion of fTg catalyzed by Tam treatment is represented.
(B) Tam-induced Cre recombinase deletion of WT eIF2a fTg is specific. Pancreatic tissue sections obtained from mice 3 weeks after Tam administration were
triple immunostained for EGFP, insulin, and glucagon, and representative single-channel fluorescence images are shown individually and merged (lower-right
image of each group). Scale bar, 20 mm.
(C) Tam-induced Cre recombinase deletion of WT eIF2a fTg is efficient. The WT eIF2a fTg directs high-level conditional expression of WT eIF2amRNA in b cells.
Tamwas administered to all mice, and after 3 weeks, total RNAwas prepared from isolated islets. Results from quantitative RT-PCR analyses of transgenic, total,
and endogenous eIF2a mRNAs are shown. n = 3 mice per group.
(D–F) eIF2a phosphorylation is required to attenuate protein synthesis in b cells. Islets from Tam-injected A/A;fTg/0 and A/A;fTg/0;CreER/0 mice were isolated
and preincubated for 1 hr in Kreb’s buffer containing basal 2.8 mM glucose, followed by incubation for 1 hr in buffer containing 2.8 mM, 16.7 mM glucose, or 16.7
mMglucose and 1 mM thapsigargin (Tg). Metabolic labeling with [35S] methionine and cysteine was performed during the last 20min of incubation as described in
the Experimental Procedures. (D and E) Proinsulin synthesis wasmeasured by immunoprecipitation from labeled extracts. (D) Immunoprecipitated samples were
subjected to acrylamide gel electrophoresis and autoradiography. (E) Quantitation of labeled proinsulin by phosphorimaging is expressed as the fold change
relative to A/A;fTg/0 islets incubated with 2.8 mM glucose. (F) Total protein synthesis was quantified by TCA precipitation of labeled extracts and scintillating
counting, and results were normalized to total protein. n = 3 samples per group.
(C, E, and F) Data are mean ± SEM.Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc. 15
Cell Metabolism
Translational Control Maintains Insulin Productionand morphologically indistinguishable from WT S/S and hetero-
zygous S/A mice (Figures 2B, 2D, S5, and S8).
Deletion of the Floxed WT eIF2a Transgene
in Pancreatic b Cells Is Efficient
Tostudy the roleof eIF2aphosphorylation inpancreaticbcells,we
crossed the rescued A/A;fTg/0 mice with RIP-CreER (CreER/0)
mice that express an estrogen receptor-Cre recombinase fusion
protein (CreER) under control of the rat insulin II promoter (RIP)
(Dor et al., 2004). Tamoxifen (Tam) administration in this system
results in a rapid nuclear translocation of the CreER protein,
permitting CreER-mediated recombination (Figure 1A). Triple-im-
munostaining analyses of pancreatic sections for insulin, EGFP,
and glucagon revealed that Tam treatment to delete the eIF2a-
coding sequence induced EGFP expression in more than 95%
of the b cells in islets of S/A;fTg/0;CreER/0 mice (Figure 1B and
data not shown).
TheefficiencyofCre-mediated recombinationwas furtherchar-
acterized at the expression level using quantitative real-time
RT-PCR of total islet RNA (Figure 1C). At 3 weeks after Tam injec-
tion, the amount of transgene-driven floxed eIF2a TgmRNA was
decreased to 20% in islets from both S/A;fTg/0;CreER/0 and
A/A;fTg/0;CreER/0mice compared to islets from A/A;fTg/0mice
that do not express CreER (Figure 1C, left). Similarly, although
the amount of total eIF2a mRNA was increased 11-fold due to
fTg expression, after Tam treatment, the total amount of eIF2a
mRNA was decreased to the level of endogenous eIF2a mRNA
(Figure 1C, middle). Residual fTg mRNA detected in these islet
preparations after Tam treatment may be due to fTg expression
in other non-b cell types of the islet preparations. The presence
of fTgdid not significantly altermRNAexpression from the endog-
enous eIF2a alleles (Figure 1C, right). These results collectively
affirm that this CreER/loxP system specifically and efficiently
removes the floxed WT eIF2a transgene in pancreatic b cells.
eIF2a Phosphorylation Is Required to Attenuate
Protein Synthesis in b Cells
To elucidate the impact of the eIF2a Ser51Alamutation on regu-
lation of protein synthesis, we performed metabolic labeling
in islets treated with low glucose to repress translation; high
glucose to stimulate translation (Itoh andOkamoto, 1980;Wicks-
teedet al., 2003); and thapsigargin (Tg) to induceERstress,PERK
activation, and eIF2a phosphorylation (Harding et al., 2000).
Whencultured in lowglucose, proinsulin synthesiswas increased
5-fold in A/A;fTg/0;CreER/0 islets compared to A/A;fTg/0 islets
isolated at 10 weeks after Tam treatment (Figures 1D and 1E).
Additionally, in high glucose, proinsulin translation in A/A;fTg/0;
CreER/0 islets was significantly greater than in A/A;fTg/0 islets.
Finally, thapsigargin partially inhibited glucose-stimulated proin-
sulin translation in A/A;fTg/0 islets, but not in A/A;fTg/0;CreER/0
islets (Figures 1D and 1E). These differences were also reflected
in total protein synthesis (Figure 1F). Therefore, eIF2a phosphor-
ylation-deficientbcells exhibit anunrestricted,high rateofprotein
synthesis that is not repressed by low glucose or ER stress.
Glucose Homeostasis and Adult b Cell Survival
Require Translation Attenuation
Tam administration to A/A;fTg/0 mice and to heterozygous S/A;
fTg/0;CreER/0mice did not alter fasting blood glucose levels up16 Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc.to 11 weeks because these mice retain the capacity for eIF2a
phosphorylation in b cells due to the floxed WT eIF2a transgene
orWT eIF2a allele (S) (Figures 2A and 2B). In contrast, mild hyper-
glycemia inA/A;fTg/0;CreER/0micewas detectable at7weeks
after Tam treatment and became severe after 11 weeks (Fig-
ures 2A, 2B, and S3). At 3 weeks after Tam injection, glucose
clearance was abnormal in A/A;fTg/0;CreER/0 male mice and
became increasingly more aberrant over 15 weeks (Figure 2B).
As commonly observed in models of b cell failure (Le May
et al., 2006), the hyperglycemic phenotype of female A/A;fTg/0;
CreER/ mice was milder than that observed in the male animals
(Figure S5). These results indicate that a b-cell-specific defect in
eIF2a phosphorylation compromises b cell function and disrupts
glucose homeostasis in adult mice.
To discern whether loss of glycemic control was associated
with a reduced bcellmass, isletmorphology, serum insulin levels,
and pancreatic insulin content were evaluated at 3–15 weeks
after Tam injection. Although there was not a significant differ-
ence at 3 weeks after Tam injection, after 6–15 weeks, the
number of cells that were immunoreactive with both insulin and
EGFP antibodies was severely reduced in islets from A/A;fTg/0;
CreER/0 mice compared to control mice, whereas there was no
change in the mantle of glucagon-producing a cells (Figures 2C,
third column, 3D, and S6). Compared to control A/A;fTg/0mice,
pancreatic insulin content was decreased by 88%, and blood
insulin level was decreased by 78% in A/A;fTg/0;CreER/0
mice at 15 weeks after Tam injection (Figure 2D). These studies
suggest that the b cell mass of A/A;fTg/0;CreER/0 mice is
reduced due to cell death.
To analyze b cell death more directly, TUNEL staining was
employed. At 3 and 8 weeks after Tam injection, a significant
number of apoptotic islet cells were detected in pancreata from
A/A;fTg/0;CreER/0 mice, whereas TUNEL-positive cells were
rarely detected within islets of S/A;fTg/0;CreER/0 or A/A;fTg/0
mice (Figures 2E and S4). Therefore, b cell apoptosis likely
causes the development of hypoinsulinemia, severe glucose
intolerance, and hyperglycemia in these animals.
Translation Attenuation Is Required for Optimal
Expression of UPR Genes, Oxidative Stress Response
Genes, and b-Cell-Specific Genes
To provide insight into the requirement for eIF2a phosphorylation
in b cells, we compared gene expression in islets from A/A;fTg/0;
CreER/0 mice to A/A;fTg/0 mice. The expression of the majority
of UPR genes, including Xbp1, was significantly decreased in
islets from A/A;fTg/0;CreER/0 mice at 3 weeks after Tam treat-
ment (Figures 3A and 3B). This is reminiscent of the defect in
UPR gene induction observed in Perk-null and eIF2a A/A fibro-
blasts treated with pharmacological ER stress inducers (Calfon
et al., 2002; Lu et al., 2004; Scheuner et al., 2001). We confirmed
that the ER stress induction of a major proportion of UPR genes
was also defective in homozygous eIF2a A/A immortalized
hepatocytes (Figure S7). Therefore, optimal expression of many
UPR-regulated genes apparently requires eIF2a phosphoryla-
tion in fibroblasts and hepatocytes, as well as in b cells in vivo.
These findings indicate that there may be defects in ER protein
folding and/or degradation in eIF2a phosphorylation-deficient
b cells. In addition, these results indicate that ER stress is not
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Translational Control Maintains Insulin ProductionFigure 2. b-Cell-Specific Deletion of WT eIF2a fTg Causes Glucose Intolerance Due to Reduced Islet Mass
(A) At the indicated weeks after Tam injection, blood glucose measurements were performed in mice fasted for 5–6 hr. n = 5–6 mice per group. Significant differ-
ences between A/A;fTg/0 versus A/A;fTg/0;CreER/0 mice are indicated.
(B) GTTs were performed at 3–15 weeks after Tam administration. n = 5–6 mice per group. Significant differences between A/A;fTg/0 versus A/A;fTg/0;
CreER/0 mice are indicated.
(C) Pancreatic tissue sections obtained from mice at the indicated times after Tam administration were triple immunostained for insulin, EGFP, and glucagon.
Representative single-channel fluorescence images are shown individually and merged (lower-right image of each group). Scale bar, 20 mm.
(D) Serum insulin levels and pancreatic insulin content were measured in mice at 3 and 15 weeks after Tam injection. Pancreatic insulin (Ins) measurements were
normalized to glucagon (Glu). n = 3–7 mice per group.
(E) TUNEL staining was performed on pancreatic sections obtained frommice at 3 weeks after Tam injection, and the number (#) of positive (+) cells per islet area
was quantified. n = 5–7 mice per group. Scale bars, 50 mm.
(A, B, D, and E) Data are mean ± SEM.necessarily associated with elevated UPR gene expression,
especially when ER stress signaling pathways are defective.
Further analysis demonstrated that expression levels of the
b-cell-specific transcription factors Pdx1 and MafA and their
target genes Ins1, Ins2, Iapp, and Glut2 were significantly
decreased in A/A;fTg/0;CreER/0 islets compared to A/A;fTg/0
islets (Figure 3C). Furthermore, immunofluorescence analysis
for Pdx1 and MafA proteins showed reduced nuclear staining
in A/A;fTg/0 islets (Figure 3D). In contrast, the expression levels
of Beta2, Ngn3, and the a-cell-specific gene Gcg (glucagon)
were not altered in A/A;fTg/0;CreER/0 islets. In addition, the
expression levels of the antioxidant response genes Sod2,
Ucp2, and Pparg were decreased in A/A;fTg/0;CreER/0 islets
compared to A/A;fTg/0 islets (Figure 3E). Finally, the expression
of Tnfa, Tnfr1, and A20 and p21Waf/Cip downstream in TNFa
signaling was increased in A/A;fTg/0;CreER/0 islets (Figure 3F).Importantly, this indicates that unabated protein synthesis is
sufficient to initiate a proinflammatory response in the islet. In
summary, the expression analyses suggest that eIF2a phos-
phorylation may be required to regulate expression of genes
that limit oxidative stress and preserve b cell function.
ER Distention and Mitochondrial Damage Occur in the
Absence of Translational Control
The increased protein synthesis and reduced expression of ER
chaperones suggested that the protein-folding load may exceed
the protein-folding capacity of the ER, leading to ER stress in
cells that lack eIF2a phosphorylation. Ultrastructural analysis
of islets fromA/A;fTg/0;CreER/0mice at 3weeks after Tam injec-
tion revealed a mixed population of b cells, with 46% (Figure 4B)
exhibiting abnormal ER morphologies (arrows in Figures 4A and
S8A) indicative of ER stress (Scheuner et al., 2005). However, atCell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc. 17
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(A–C, E, and F) Total RNA was extracted from islets isolated from mice at 3 weeks after Tam administration. Expression levels of mRNA were measured using
quantitative RT-PCR. Data are mean ± SEM. n = 5–6 mice per group.
(A) Genes regulated through eIF2a phosphorylation.
(B) Genes regulated through IRE1a signaling and genes of ERAD machinery.18 Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc.
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detectably reduced (Figures 4A, middle, and S8A). At 11 weeks
after Tam injection, more extensive abnormalities, including ER
distention, low-electron-density vesicular structures, and re-
ducedgranule number,were observed, coincidentwithmarkedly
diminished b cell mass in the A/A;fTg/0;CreER/0 mice (Figures
S8C and S8D). These findings indicate that ER distention and
dysfunction precede the loss of secretory granule content.
Interestingly, we observed abnormally large or oval mitochon-
dria in b cells from A/A;fTg/0;CreER/0mice at 3 weeks after Tam
treatment (arrowheads in Figures 4A, S8A, and S8B). Most of the
b cells that had distended ER in islets from transgene-deleted
A/A;fTg/0;CreER/0 mice also displayed swollen mitochondria
with disrupted cristae. In addition, some b cells were extraordi-
narily enlarged (one or two b cells per islet in 40% of the islets
within pancreata of A/A;fTg/0;CreER/0 mice) (Figures 4A, third
panel, andS8B),with ERdistention andmitochondrial swelling as
observed in type 3B (cytoplasmic type) cell death (Clarke, 1990).
The ultrastructural analyses demonstrate that translational
control through eIF2a phosphorylation is essential to preserve
the structural integrity of the ER and to prevent mitochondrial
damage.
Proteins Are Mislocalized in the Absence
of eIF2a Phosphorylation
The abnormal ER observed in eIF2a phosphorylation-deficient
b cells motivated us to analyze the subcellular localization of
proinsulin, E-cadherin (E-cad), andGLUT2 as proteins that traffic
the secretory pathway en route to secretory granules and the
plasmamembrane. Immunofluorescence analysis demonstrated
that proinsulin was confined to the perinuclear area of b cells in
S/A;fTg/0;CreER/0 (data not shown) and A/A;fTg/0 pancreata,
a distribution that corresponds to the Golgi apparatus (Zhu
et al., 2002) (Figure 4C, left). In contrast, the localization of proin-
sulin in b cells from A/A;fTg/0;CreER/0 mice at 3 and 8 weeks
after Tam treatment was less restricted where it appeared intra-
cellularly, both diffusely and in large aggregates (Figure 4C,
middle and right), possibly reflecting accumulation of proinsulin
in an expandedERcompartment, as suggested by the ultrastruc-
tural analyses (Figure 4A). In addition, there was increased intra-
cellular localization and reduced plasma membrane localization
of both E-cad (Figure 4D) and Glut2 (Figure 4E) in b cells from
A/A;fTg/0;CreER/0 mice compared to S/A;fTg/0;CreER/0 and
A/A;fTg/0 mice at 3 and 8 weeks after Tam treatment. These
findings support the hypothesis that eIF2a phosphorylation is
required to limit translation and prevent misfolding and/or reten-
tion of secretory andplasmamembrane proteins in the ER lumen.
eIF2a Phosphorylation Is Required to Limit Oxidative
and Nitrosative Damage in Pancreatic b Cells
Because ultrastructural analyses suggested mitochondrial
damage (Figure 4A) and gene expression analyses indicated a
reduced antioxidant response (Figure 3E) in A/A;fTg/0;CreER/0islets, we analyzed oxidative damage in control and mutant
islets. Cellular protein damage due to oxidative stress can occur
when superoxide reacts with nitric oxide, leading to peroxynitrite
modification of tyrosine residues. Anti-nitrotyrosine-specific anti-
bodies intensely stained islets ofA/A;fTg/0;CreER/0mutant pan-
creata compared to islets of A/A;fTg/0 and S/A;fTg/0;CreER/0
mice at 3 weeks after Tam injection (Figures 5A and 5B). Consis-
tent with the nitrotyrosine immunostaining results, protein oxida-
tion (carbonyls) and lipid peroxidation (hydroxyoctadecadienoic
acid [HODE]) were significantly elevated in islet samples from
A/A;fTg/0;CreER/0 mice compared to A/A;fTg/0 mice at a time
prior to development of hyperglycemia (3 weeks after Tam treat-
ment) (Figures 5C and 5D). In addition, direct treatment of WT
S/S islets in vitro with tunicamycin (Tm) to inhibit glycosylation
and disrupt protein folding also increased protein oxidation
and lipid peroxidation, indicating that the accumulation of mis-
folded protein in the ER is sufficient to induce oxidative stress
in the islets (Figure 5D). These data indicate that PERK-eIF2a
signaling is required in pancreatic b cells to limit oxidative
damage that may result from excessive protein synthesis and
accumulation of misfolded proteins in the ER. However, analysis
ofAtf4-null mice demonstrated that ATF4 is not required for b cell
function, suggesting that the b cell requirement for eIF2a phos-
phorylation is not mediated through selective translation of Atf4
mRNA (see Supplemental Results and Figure S9).
To assess the significance of oxidative stress in the b cell
failure that occurs in the absence of eIF2a phosphorylation,
we analyzed the effect of antioxidant treatment in A/A;fTg/0;
CreER/0mice. Groups of A/A;fTg/0 and A/A;fTg/0;CreER/0mice
were fed with regular chow or chow supplemented with the anti-
oxidant butylated hydroxyanisole (BHA) (Malhotra et al., 2008)
just prior to and following Tam treatment. The early development
of glucose intolerance in A/A;fTg/0;CreER/0 mice induced at
3–8 weeks after Tam treatment was reduced by BHA administra-
tion (Figures 6A and S10). The protection persisted for 15 weeks,
although the effect was less profound at later times. To deter-
mine how antioxidant treatment preserves glucose homeostasis
in mice lacking phosphorylation of eIF2a in b cells, we analyzed
serum and pancreatic insulin levels and b cell death. At 6 weeks
after Tam treatment, the levels of serum and pancreatic insulin
were modestly increased in A/A;fTg/0;CreER/0 mice fed BHA-
containing chow compared to regular chow (Figure 6B). In addi-
tion, there was reduced apoptosis in islets from A/A;fTg/0;
CreER/0 mice fed BHA-containing chow compared to regular
chow (Figures 6C and 6D). These data indicate that deficiency
of eIF2a phosphorylation in pancreatic b cells causes oxidative
damage-induced cell death that can be partially prevented by
antioxidant treatment.
DISCUSSION
Phosphorylation of eIF2a at Ser51 is an evolutionarily conserved
regulatory mechanism that efficiently attenuates the rate of(C) Pancreatic b- or a-cell-specific genes.
(D) PDX1, MafA, and insulin immunolabeling of pancreatic sections were conducted on samples isolated from mice at 6 weeks after Tam administration. Repre-
sentative merged images of PDX1 with insulin (top) and MafA with insulin (bottom) are shown. Scale bars, 20 mm.
(E) Antioxidant response genes.
(F) Anti- and proapoptotic genes.Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc. 19
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(A and B) TEM was performed on pancreatic sections from A/A;fTg/0 and A/A;fTg/0;CreER/0 mice at 3 weeks after Tam administration, and representative
images are shown. In the A/A;fTg/0 image, arrows indicate normal ER regions, and arrowheads demark normal mitochondria. In A/A;fTg/0;CreER/0 images,20 Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc.
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Translational Control Maintains Insulin ProductionFigure 5. Translation Attenuation Is Required to Prevent Oxidative Stress in b Cells
(A andB) Immunohistochemistrywasperformed todetect nitrotyrosine in pancreatic sections frommice at 3 and8weeks after Tamadministration.Representative
images and quantitation of the number (#) of nitrotyrosine-positive (+) b cells per islet area are shown. n = 5–7 mice per group. Scale bars, 50 mm.
(C andD) Protein carbonyls (C) andHODEs (D) were quantified in extracts from islets freshly isolated frommice at 3weeks after Tam injection. n = 7mice per group.
Isletswere isolated fromWTS/Smice and in vitro incubated in the absence or presence of tunicamycin (Tm, 2 mg/ml) for 5 hr prior to analysis of oxidation products.
(B–D) Data are mean ± SEM.translation in all eukaryotic cells, from protozoa to plants and hu-
mans. Thus, it is remarkable that mice harboring homozygous
Ser51Alamutation (A/A) at the phosphorylation site within eIF2a
develop to birth yet have embryonic b cell failure and die perina-
tally (Scheuner et al., 2001). Through expression of a b-cell-
specific WT eIF2a transgene, we demonstrate that embryonic
development of b cell mass requires eIF2a phosphorylation.
However, perinatal lethality was only rescued by ubiquitous
expression of WT eIF2a. Through design of a conditional ubiqui-
tously expressed WT eIF2a transgene, we demonstrated that
eIF2a phosphorylation is required for maintenance and function
of differentiated b cells. Our results demonstrate that Tam-
induced b-cell-specific eIF2a fTg deletion in homozygous eIF2a
Ser51Ala mice disrupts ER homeostasis, prevents polypeptide
trafficking through the secretory pathway, causes mitochondrialdamage and oxidative stress, depletes insulin-containing gran-
ules, and induces apoptosis in b cells (Figure 7). These alter-
ations were accompanied with reduced expression of UPR
genes, antioxidative stress response genes, and b-cell-specific
genes. The dire consequences of uncontrolled proinsulin syn-
thesis in the absence of eIF2a phosphorylation bear a striking
similarity to the b cell failure that occurs in type 2 diabetes, in
which the demand for insulin production is increased (Prentki
and Nolan, 2006). We have described a unique model in which
b cell failure is associated with a primary increase in protein
synthesis, which may recapitulate events that occur in b cells as
they increase proinsulin expression to compensate for insulin
resistance.
Compared to other cell types, b cells have the unique ability to
couple protein synthesis with changes in blood glucose. Recentarrows indicate regions of severe ER distention, asterisks indicate abnormal structures of low electron density, and arrowheads demark swollen mitochondria.
Scale bars, 2 mm. (B) The percentage of b cells with dilated ER at 3 weeks was quantified. Data are mean ± SEM. n = 5–7 mice per group.
(C–E) Pancreata frommice at 3 and 8 weeks after Tam administration were analyzed by immunofluorescence for proinsulin (C), E-cad (D), and GLUT2 and EGFP
(E). In (C) and (E), single-channel fluorescence images (top) and merged images (bottom) are shown. In (D), merged images are shown. Scale bars, 20 mm.Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc. 21
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Translational Control Maintains Insulin ProductionFigure 6. Antioxidant Treatment Preserves Insulin Production,ReducesbCell Death, and ImprovesGlucose Intolerance inA/A;fTg/0;CreER/0
Mice
(A) GTTs were performed on mice fed chow supplemented with or without BHA for 3–15 weeks after Tam treatment. The area under the curve (A.U.C.) from the
GTTs was quantified. n = 5–6 mice per group.22 Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc.
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Translational Control Maintains Insulin ProductionFigure 7. Mechanism for Dysfunction and Death of eIF2a Phosphorylation-Deficient b Cells
Fluctuations in glucose regulate eIF2a kinases and phosphatases to control eIF2a phosphorylation and the rate of mRNA translation in the b cell (left). A feedback
loop attenuates mRNA translation through PERK activation in response to misfolded proteins. Phosphorylation of eIF2a is required for translation of Atf4mRNA
that leads to transcriptional induction. Increased expression of GADD34 causes dephosphorylation of eIF2a to increase mRNA translation. The eIF2a A/Amuta-
tion prevents low glucose repression of protein synthesis and causes unrestricted high rates of mRNA translation (right). Elevated protein synthesis leads to the
accumulation of misfolded proteins in the ER. The absence of eIF2a phosphorylation eliminates PERK-mediated feedback inhibition of protein synthesis and
reduces expression of UPR genes and antioxidant response genes, thereby exacerbating the protein-folding defect. Accumulation of misfolded proteins in
the ER initiates production of ROS. ROS may inactivate b-cell-specific transcription factors, leading to insulin granule depletion. b cells ultimately succumb to
apoptosis. Pathways associated with eIF2a phosphorylation (red) and dephosphorylation (green).studies suggest that this regulation may be mediated through
eIF2a phosphorylation (Gomez et al., 2008; Vander Mierde
et al., 2007). Both eIF2a Ser51Ala mutation and Perk deletion
in b cells cause a higher rate of translation that is not repressible
under ER stress conditions (see Figure 4 in Harding et al., 2001
and our Figures 1D–1F). These findings indicate that PERK-
mediated phosphorylation of eIF2a controls the maximal rate
of translation under these conditions. However, under conditions
of low glucose, translation was not repressed in islets from
homozygous eIF2a Ser51Ala mice. This is in contrast to transla-
tion in Perk/ islets that was repressed by low glucose (Harding
et al., 2001). Therefore, although our studies show a requirement
for eIF2a phosphorylation for translation attenuation in response
to low glucose, it is unlikely that PERK is the sole eIF2a kinase
responsible.
Our findings show that eIF2a phosphorylation is required for
function and survival of differentiated b cells and are consistent
with the b cell failure observed upon deletion of Perk in humansand mice (Delepine et al., 2000; Harding et al., 2001; Zhang et al.,
2002). In contrast, analysis of murine b-cell-specific Perk deletion
indicated that PERK is not required to maintain b cell function
(Zhang et al., 2006). It is possible that a partial reduction in eIF2a
phosphorylation,asoccurs in thedeletionofanysingleeIF2akinase
gene,maynot significantly affect protein synthesis toelicit apheno-
type in b cells. Alternatively, it is possible that b cells adapt to Perk
deletion by compensatory mechanisms, possibly by increasing
activity of alternate eIF2a kinase(s). Additional mechanisms that
could account for the differences between b-cell-specific Perk
deletion and eIF2a Ser51Ala mutation, such as deletion efficiency
and strain variation, are discussed in the Supplemental Discussion.
We have shown that unregulated protein synthesis is sufficient
to initiate a series of events that leads to ROS production and
b cell failure. Multiple sourcesmay contribute to ROS production
in the absence of eIF2a phosphorylation. It is proposed that
hyperglycemia and/or hyperlipidemia associated with insulin
resistance contribute to ROS production in b cells (Kajimoto(B) Blood glucose (left), serum insulin (middle), and pancreatic insulin (right) were measured in A/A;fTg/0 and A/A;fTg/0;CreER/0mice at 6 weeks after Tam injec-
tion with and without BHA feeding. Pancreatic insulin measurements were normalized to glucagon (Glu). n = 7–9 mice per group.
(C and D) TUNEL staining was performed on pancreatic sections obtained frommice at 6 weeks after Tam injection, and the number (#) of positive (+) cells per islet
area was quantified. n = 7–9 mice per group. Scale bars, 50 mm.
(A, B, and D) Data are mean ± SEM.Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc. 23
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Translational Control Maintains Insulin Productionand Kaneto, 2004; Robertson et al., 2007). We believe that
hyperglycemia is unlikely to initiate the ROS-dependent b cell
failure in our model because fed and fasted blood glucose levels
were not significantly increased in the eIF2a fTg-deleted homo-
zygous eIF2aA/Amice at 3weeks after Tam injection (Figures 2A
and 2B and data not shown), a time at which increased oxidative
damage was detected (Figure 5). Alternatively, ROS production
may result from changes in gene expression that occur in the
absence of eIF2a phosphorylation, such as reduced expres-
sion of genes encoding antioxidant functions (Sod2, Ucp2, and
Pparg) (Brand and Esteves, 2005; Jo et al., 2006) or increased
expression of genes that function in TNFa signaling (Tnfa,
Tnfr1, A20, and p21) and contribute to ROS production (O’Reilly,
2005; Xue et al., 2005). It is also possible that uncontrolled protein
synthesis increases oxidative protein folding and/or protein mis-
folding, both of which may initiate ROS production (Harding
et al., 2003; Malhotra et al., 2008; Merksamer et al., 2008; Teck-
man et al., 2004). Our ultrastructural analysis demonstrated that
mitochondrial swelling occurs in the eIF2a phosphorylation-defi-
cient b cells, suggesting that altered mitochondrial function may
play a role in ROS production. As oxidative stress is associated
with b cell failure in type 2 diabetes (Lowell and Shulman, 2005;
Robertson et al., 2007), more extensive studies on the mecha-
nism of ROS production in these mice should provide important
insight into fundamental causes of b cell failure in humans.
Ultrastructural analysis and immunolocalization of proinsulin,
GLUT2, and E-cad revealed that, in the absence of eIF2a phos-
phorylation, secretory proteins accumulate in the ER. This may
be a consequence of uncontrolled protein synthesis or reduced
protein folding and/or ERAD capacities as a consequence of
decreased expression of UPR genes. Although it is surprising
that both hepatocytes and b cells require eIF2a phosphorylation
for an intact UPR, this observation is consistent with earlier
reports (Lu et al., 2004; Scheuner et al., 2001) and is not affected
by a general cell death, as our studies were performed prior to
significant loss of cell mass or viability in b cells and hepatocytes,
respectively. Present studies are directed to understand why
eIF2a phosphorylation is required for optimal UPR induction.
Reduced expression of UPR genes could well contribute to the
defective cargo export from the ER. For example, eIF2a phos-
phorylation-deficient b cells have decreased expression of both
Ero1a and Ero1b, which are required to maintain PDI in an active
state to promote proper disulfide bond formation. Alternatively,
eIF2a phosphorylation-deficient b cells also express lower levels
of mRNA encoding p58IPK, a cochaperone for BiP that protects
cells from ER stress (Rutkowski et al., 2007). Indeed, p58IPK
knockout mice display pancreatic b cell failure and diabetes (La-
diges et al., 2005).
Our studies show that eIF2a phosphorylation is required for
b cell function/survival. Analysis of mRNA expression and immu-
nostaining demonstrated that eIF2a phosphorylation maintains
expression of PDX1 and MafA, transcription factors necessary
for b cell differentiation, proliferation, and survival (Ackermann
and Gannon, 2007; Ahlgren et al., 1998; Kaneto et al., 2008;
Zhang et al., 2005). However, the Pdx1 and MafA genes do not
contain any known ER stress response elements (data not
shown) and are not known to be directly regulated by the UPR
or eIF2a phosphorylation. It is possible that eIF2a phosphoryla-
tion promotes mRNA translation of a factor required to maintain24 Cell Metabolism 10, 13–26, July 8, 2009 ª2009 Elsevier Inc.differentiated b cells. We have shown that ATF4, the most well-
characterized mRNA that requires eIF2a phosphorylation for
translation, is not necessary for b cell function (Figure S7). There-
fore, selective translation of one or more alternate mRNAs
may be required. Alternatively, eIF2a phosphorylation may be
required to prevent excessive protein synthesis in the b cell to
limit protein misfolding and oxidative stress. Oxidative stress
waspreviously implicated in decreasing expression of bothPDX1
and MafA protein (Kaneto et al., 2008; Robertson et al., 2007).
We attribute the loss of expression of b-cell-specific genes in
the absence of eIF2a phosphorylation to decreases in PDX1
and MafA through one or more of these mechanisms.
We have described a conditional eIF2a Ser51Ala mouse
model based on Cre recombinase-mediated excision of a sup-
porting transgene that can be used to study the role of eIF2a
phosphorylation in any tissue. This model will provide a platform
for additional mechanistic studies on the role of eIF2a phosphor-
ylation in many physiological processes, including metabolic
disease, carcinogenesis andmetastasis, hypoxia, infectious and
inflammatory diseases, and functions of the nervous system.
EXPERIMENTAL PROCEDURES
Mouse Strains and Animal Procedures
Details of founder analysis, strain interbreeding, and PCR genotyping are
provided in the Supplemental Experimental Procedures and Table S4. Hetero-
zygous eIF2a Ser51Ala (S/A) mice were generated as previously described
(Scheuner et al., 2005). Transgenic mice (b-Tg/0) expressing WT eIF2a (b-Tg)
driven by the rat Insulin II promoter (RIP) (Figure S1A) were derived as
described in Supplemental Experimental Procedures. Conditional transgenic
mice (fTg/0) that express excisable floxed WT eIF2a (fTg) in all tissues were
derived from a plasmid construct (pCX-EGFP) containing cytomegalovirus
enhancer, chicken b-actin promoter, b-actin intron, enhanced green fluores-
cence protein (EGFP), and a bovine globin polyadenylation signal (a gift of
Dr. Masaru Okabe, Osaka University) (Okabe et al., 1997). Modifications were
performed to flank the WT murine eIF2a cDNA with loxP sequences and to
position EGFP downstream of eIF2a (Figure 1A) as described in the Supple-
mental Experimental Procedures. Mice (CreER/0) expressing an estrogen
receptor-Cre recombinase fusion protein (CreER) under the control of the rat
Insulin II promoter (RIP) were kindly provided by Dr. Douglas A. Melton, Har-
vard University Medical Center (Dor et al., 2004).
Animals were housed at 21C –23C with 12 hr light and 12 hr dark cycles in
the Unit for Laboratory Animal Medicine (ULAM) at The University of Michigan,
with free access to water and standard rodent chow (LabDiet Formulab Diet
no. 5001). Butylated hydroxyanisole (BHA)-containing chow (Sigma) was
formulated by Research Diets, Inc., with 0.7% BHA in a base of LabDiet
Formulab Diet no. 5001. BHA diet study mice were housed pairwise.
Deletion of the fTg in pancreatic b cells was induced by subcutaneous injec-
tion of tamoxifen (Tam; Sigma) dissolved in corn oil (20 mg/ml). Five doses of
8 mg Tam were administered over 2 weeks to 3- to 5-month-old mice (Dor
et al., 2004). In every experiment, all genotypes of mice received Tam. Tam
administration did not affect any of the parameters under analysis.
Blood glucosemeasurements and glucose tolerance testing (GTT) were per-
formed in mice fasted 5–6 hr, and serum and pancreatic insulin and glucagon
content were measured in mice fasted overnight as described (Song et al.,
2008). Measurements of body weight were performed between 3:00 and
5:00 PM.
All animal care and procedures were conducted according to the protocols
and guidelines approved by The University of Michigan Committee on the Use
and Care of Animals (UCUCA).
Islet Isolation
Islets were isolated by intraductal collagenase P (Roche) perfusion, histopa-
que-1077 gradient (Sigma), and hand picking (Sutton et al., 1986).
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Semiquantitative PCR by standard methods or quantitative real-time PCR
were performed as previously described (Back et al., 2005; Song et al.,
2008). Real-time PCR results were normalized to the levels of 18S rRNA or
b-actin, and primer sequences are provided in Table S4.
Protein Synthesis
Islets isolated from female mice (n = 7 per genotype) at 10 weeks after Tam
injection were cultured for 22 hr in RPMI 1640 medium containing 5.6 mM
glucose, 10% fetal bovine serum, and 10 mM HEPES and were pooled for
selection of 80 size-matched islets per experimental condition. Glucose-stim-
ulated protein synthesis was analyzed as previously described (Harding et al.,
2001; Wicksteed et al., 2003). Analysis of proinsulin synthesis is described in
the Supplemental Experimental Procedures.
Islet Morphology, Apoptosis, and Oxidative Damage
Pancreata were isolated, fixed with 10% buffered formalin or 4% paraformal-
dehyde, and embedded in paraffin. Sections were prepared and either stained
with hematoxylin and eosin (H&E) for visualization of islet morphology by light
microscopy or subjected to other histological procedures. TUNEL labeling
was performedon tissue sections using ApopTagPeroxidase In Situ Apoptosis
Detection Kit (CHEMICON). Nitrated proteins were detected within islets of
pancreatic sections with anti-nitrotyrosine antibody (Upstate) using Histo-
stain-plus Kit (second generation LAB-SA detection system, Zymed Laborato-
ries). The sections were then counterstained by hematoxylin (Zymed Laborato-
ries). Themeasurementsof protein carbonyls andHODEs in isolated isletswere
performed as previously described (Pennathur et al., 2005; Song et al., 2008).
Immunofluorescence
Immunofluorescence labeling was performed for detection of insulin, EGFP,
glucagon, proinsulin, GLUT2, E-cad, PDX1, and MafA. Nuclear counterstain-
ing with DAPI was performed in some instances. Multiple labeling procedures
were performed serially, and the following antibody combinations were utilized
for antigen detections: insulin, guinea pig anti-insulin antibody (Linco) and
Texas Red-conjugated donkey anti-guinea pig secondary antibody (Jackson
Immuno Research); EGFP, mouse anti-EGFP antibody (Clontech) and FITC-
conjugated goat anti-mouse secondary antibody (Jackson ImmunoResearch
Laboratories, Inc.); glucagon, rabbit anti-glucagon antibody (Linco) and Alexa
Fluor 488- or 350-conjugated goat anti-rabbit secondary antibodies (Molec-
ular Probes); proinsulin or E-cad, mouse anti-proinsulin (HyTest Ltd.) or mouse
anti-E-cad (BDBioscience) andTRITC-conjugated goat anti-mouse secondary
antibody (Jackson ImmunoResearch Laboratories, Inc.); GLUT2, MafA, or
PDX1, rabbit anti-GLUT2 (Santa Cruz), rabbit anti-MafA (Santa Cruz), or rabbit
anti-PDX1 (Upstate) and Alexa 594-conjugated goat anti-rabbit secondary
antibody (Molecular Probes).
Confocal and light microscope images were recorded digitally by camera,
and b cell mass was measured using Image-Pro Plus software (Media Cyber-
netics) (Figures S4, 5B, and 6D). All data were processed with Adobe Photo-
shop software (Mountain View).
Transmission Electron Microscopy
Transmission electron microscopy (TEM) was performed on pancreas tissue
as previously described (Scheuner et al., 2005). ER dilation was quantified
(Figure 4B) at 79003 magnification, and more than 150 b cells for each geno-
type of mice were analyzed. Dilation (>0.3 mm diameter cisternae) visible more
than four times in a cell was criteria for positive ER distention.
Statistical Analysis
All data are presented as means ± SEM. Statistical significance of difference
between groups was evaluated using a Student’s t test or ANOVA one-way
test (Tukey’s test). p < 0.05 was considered significant. *p < 0.05, **p < 0.01,
***p < 0.001.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Results, Supplemental Discussion,
Supplemental Experimental Procedures, ten figures, and four tables and can
be found with this article online at http://www.cell.com/cell-metabolism/
supplemental/S1550-4131(09)00160-0.ACKNOWLEDGMENTS
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